Phase 2 trial finds new drug (cemdisiran) safe, potentially effective for treating IgA nephropathy

(May 13, 2024)
Dr. Sean Barbour, BC Renal Glomerulonnephritis Registry's Medical Lead, partnered with international researchers to lead a small, Phase 2 clinical trial of cemdisiran.

Read about the trial

New study suggests Kidney Failure Risk Equation can support timely creation of vascular access points for kidney patients

(May 10, 2024)
Dr. Mohammad Atiquzzaman and colleagues from BC Renal found the Kidney Failure Risk Equation could be used to support better timing of vascular access point creation, which could lead to increased patient quality of life and improved outcomes.

Read about the study

New global analysis finds regional differences in hemoglobin values, points to unseen factors influencing anemia in kidney patients

(May 10, 2024)
An international collaboration, including researchers from BC Renal and UBC, found substantial regional differences in hemoglobin values in individuals with chronic kidney disease.

Read about the study

BCCDC and BC Cancer scientist launches study on cancer misinformation

(April 18, 2024)
Dr. Cheryl Peters and team will be speaking with Canadians and conducting research to better understand how online misinformation about cancer can affect people's health.

Read about the study

New study finds that cancer-causing proteins in Ewing sarcoma and prostate carcinoma prompt tumour cells to release certain RNAs to turn off the immune response

(March 28, 2024)
Dr. Poul Sorensen found that the environment around a tumour may cause inflammation and suppress the immune system, which can make it challenging to successfully treat solid tumours with immunotherapy.

Read the article

BC Children’s Hospital Research Institute brings Mini Science Night to Salmon Arm

(March 25, 2024)
Mini Science Night is a public lecture that explores the newest discoveries and innovations in health research.

Read the article

BC Renal executive director to be honoured with international research award

(March 1, 2024)
In April, Dr. Adeera Levin will be the recipient of a 2024 International Society of Nephrology (ISN) award that recognizes outstanding research in nephrology with a clinical emphasis.

Read the announcement

Government of Canada invests $20 million to improve health outcomes of children living with rare diseases

(February 28, 2024)
The federal Minister of Health announced funding for the creation of RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network, of which BC Children's Hospital Research Institute will be a part.

Read about the discovery

New class of biomarker could better predict treatment outcomes for Hodgkin lymphoma

(January 29, 2024)
Researchers with BC Cancer have discovered a way to better predict treatment outcomes in patients with relapsed and refractory, or treatment-resistant, classic Hodgkin lymphoma.

Read more about the study

Prescribing opioids to people with opioid use disorder prevented deaths in B.C.

(January 11, 2024)
New research published this week in the British Medical Journal (BMJ), evaluates the effectiveness of B.C.'s Risk Mitigation Guidance based on a study done by BCCDC.

Read about the study

More research news & stories

• Making a real difference: People who are incarcerated help peers get immunized for COVID-19 (BC Centre for Disease Control Research/Health Research BC)
• PHSA's Three-Year Research Roadmap (September 2022)